Paritaprevir Rbv published presentations and documents on DocSlides.
. and Dasabuvir +/- . RBV in . GT1b. PEARL-II. P...
-. Ritonavir . and Dasabuvir . + RBV in . GT1. SA...
Prepared by: . Sophie . Woolston. , MD and David H...
Ombitasvir + . Dasabuvir) +/- . RBV in . GT1b. PEA...
-Ritonavir. -Ombitasvir . + Dasabuvir) . + RBV in...
Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...
. and Dasabuvir + RBV in GT1. SAPPHIRE-I. Phase ...
Paritaprevir. -. Ritonavir (. Technivie. ). Prepa...
SAPPHIRE-I. Phase 3. . Treatment. . Naïve. Fel...
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
TURQUOISE-II. Phase 3. . Treatment. Naïve and ...
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...
DSV . placebo. Randomisation*. Partial blind. 1...
≥ 18 years. Chronic HCV infection. Genotype 1. ...
Randomisation. Open-label. W8. * Liver biopsy or ...
N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
. PEG alfa-. 2a . versus. INF RBV . APRICOT S...
. with Advanced Liver Disease. ALLY-3+ Study. Phas...
C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...
. + Dasabuvir) + RBV in GT1 . TURQUOISE-I. Phase...
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...
ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...
PTV150/r + OBV + . DSV . + RBV. PTV150/r + . DSV...
Last Updated: February . 21, 2014. Robert G. Gish...
Mark Sulkowski, MD . Professor of Medicine. Medic...
Out With the Old, In With the New. Current Standa...
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...
Mark S. Sulkowski, MD. Medical Director, Viral He...
C-WORTHY Study Part C: . grazoprevir. . + . elba...
HCV WORLD CAB . FEBRUARY 2014. BANGKOK, THAI...
Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...
*. 1:1. Open-label. ≥ 18 years. HCV genotype ...
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
Copyright © 2024 DocSlides. All Rights Reserved